CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019

September 17, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search